Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 USD | +3.83% | +4.93% | +24.17% |
03:26am | Immutep Raising AU$100 Million for Phase Three Trial | MT |
May. 17 | Capital One Initiates Immutep at Overweight Rating With $10 Price Target | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
54.63B | - | |||||
39.92B | ||||||
26.86B | ||||||
26.22B | ||||||
18.78B | - |